These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


278 related items for PubMed ID: 9012840

  • 1. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells.
    Coffey RJ, Hawkey CJ, Damstrup L, Graves-Deal R, Daniel VC, Dempsey PJ, Chinery R, Kirkland SC, DuBois RN, Jetton TL, Morrow JD.
    Proc Natl Acad Sci U S A; 1997 Jan 21; 94(2):657-62. PubMed ID: 9012840
    [Abstract] [Full Text] [Related]

  • 2. Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis.
    Damstrup L, Kuwada SK, Dempsey PJ, Brown CL, Hawkey CJ, Poulsen HS, Wiley HS, Coffey RJ.
    Br J Cancer; 1999 Jun 21; 80(7):1012-9. PubMed ID: 10362109
    [Abstract] [Full Text] [Related]

  • 3. Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line.
    Liu XH, Kirschenbaum A, Lu M, Yao S, Dosoretz A, Holland JF, Levine AC.
    J Biol Chem; 2002 Dec 20; 277(51):50081-6. PubMed ID: 12401798
    [Abstract] [Full Text] [Related]

  • 4. Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases.
    Matsuura H, Sakaue M, Subbaramaiah K, Kamitani H, Eling TE, Dannenberg AJ, Tanabe T, Inoue H, Arata J, Jetten AM.
    J Biol Chem; 1999 Oct 08; 274(41):29138-48. PubMed ID: 10506169
    [Abstract] [Full Text] [Related]

  • 5. Ligand-dependent activation of the epidermal growth factor receptor by secondary bile acids in polarizing colon cancer cells.
    Merchant NB, Rogers CM, Trivedi B, Morrow J, Coffey RJ.
    Surgery; 2005 Sep 08; 138(3):415-21. PubMed ID: 16213893
    [Abstract] [Full Text] [Related]

  • 6. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q, Luo X, Huang Y, Sheikh MS.
    Oncogene; 2002 Sep 05; 21(39):6032-40. PubMed ID: 12203115
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F, Rosanò L, Di Castro V, Nicotra MR, Natali PG, Bagnato A.
    Clin Cancer Res; 2004 Jul 15; 10(14):4670-9. PubMed ID: 15269139
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
    Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD, DuBois RN.
    J Clin Invest; 1997 May 01; 99(9):2254-9. PubMed ID: 9151799
    [Abstract] [Full Text] [Related]

  • 9. Role of constitutive cyclooxygenase-2 in prostaglandin-dependent secretion in mouse colon in vitro.
    MacNaughton WK, Cushing K.
    J Pharmacol Exp Ther; 2000 May 01; 293(2):539-44. PubMed ID: 10773026
    [Abstract] [Full Text] [Related]

  • 10. Rapid and transient induction of cyclo-oxygenase 2 by epidermal growth factor in human amnion-derived WISH cells.
    Perkins DJ, Kniss DA.
    Biochem J; 1997 Feb 01; 321 ( Pt 3)(Pt 3):677-81. PubMed ID: 9032453
    [Abstract] [Full Text] [Related]

  • 11. TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer.
    Merchant NB, Voskresensky I, Rogers CM, Lafleur B, Dempsey PJ, Graves-Deal R, Revetta F, Foutch AC, Rothenberg ML, Washington MK, Coffey RJ.
    Clin Cancer Res; 2008 Feb 15; 14(4):1182-91. PubMed ID: 18281553
    [Abstract] [Full Text] [Related]

  • 12. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
    Erickson BA, Longo WE, Panesar N, Mazuski JE, Kaminski DL.
    J Surg Res; 1999 Jan 15; 81(1):101-7. PubMed ID: 9889067
    [Abstract] [Full Text] [Related]

  • 13. Synthetic pathways of gallbladder mucosal prostanoids: the role of cyclooxygenase-1 and 2.
    Longo WE, Panesar N, Mazuski JE, Kaminski D.
    Prostaglandins Leukot Essent Fatty Acids; 1999 Feb 15; 60(2):77-85. PubMed ID: 10328326
    [Abstract] [Full Text] [Related]

  • 14. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS.
    Cancer Res; 2002 Jan 01; 62(1):165-70. PubMed ID: 11782374
    [Abstract] [Full Text] [Related]

  • 15. Cyclooxygenase (COX)-2-dependent effects of the inhibitor SC236 when combined with ionizing radiation in mammary tumor cells derived from HER-2/neu mice.
    Lanza-Jacoby S, Dicker AP, Miller S, Rosato FE, Flynn JT, Lavorgna SN, Burd R.
    Mol Cancer Ther; 2004 Apr 01; 3(4):417-24. PubMed ID: 15078985
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
    Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM.
    Cancer Res; 2000 Dec 15; 60(24):6846-50. PubMed ID: 11156377
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M, Tsuji S, Tsujii M, Irie T, Komori M, Kimura A, Nishida T, Kakiuchi Y, Kawai N, Murata H, Horimoto M, Sasaki Y, Hayashi N, Kawano S, Hori M.
    Cancer Res; 2003 Oct 15; 63(20):6726-34. PubMed ID: 14583467
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.